Challenges in Diagnostic and Management of Nephritic Syndrome in Diabetic Nephropathy Patient: a Case Report

Authors

  • Adinda Dian Novitasari Universitas Brawijaya
  • Nur Samsu Nephrology and Hypertension, Department of Internal Medicine, Faculty of Medicine, Universitas Brawijaya, Malang Indonesia

DOI:

https://doi.org/10.21776/ub.crjim.2021.002.01.7

Keywords:

nephitic syndrome, diabetic nephropathy, diabetes mellitus, skin ulcer.

Abstract

The clinical presentation of patients with acute glomerulonephritis (GN) varies widely, from asymptomatic to clinical presentations of acute kidney injury (AKI), edema, and hypertension. Diagnosis of GN in patients with diabetic nephropathy (DN) is a challenge due to pre-existing edema, hypertension, and decreased renal function. Likewise in terms of management of steroid immunosuppressants related to blood sugar regulation. It has been reported that 35-year-old male patients with diabetes mellitus (DM) with DN whose kidney function deteriorated rapidly. The patient complained of cola-red urine and decreased urine volume the day before admission. Physical examination showed blood pressure of 160/95 mmHg, bilateral leg edema, active chronic ulcer in the left lower leg, hemoglobin level was 8.7 g / dl, leukocytes 17.400 / ul, serum urea level 96 mg / dl, serum creatinine level 7.01 mg / dl, ASTO titer + 800 IU / ml, macroscopic hematuria, and albuminuria +4 on urinalysis. Ultrasonography revealed enlarged kidney size and signs of acute renal inflammation. Based on these data the patient was diagnosed clinically as rapidly progressive GN due to post-infectious GN. The patient received 3 days of pulse methyl prednisolone therapy continued orally, blood sugar regulation with insulin, RAS blockers, intravenous antibiotics and ulcer debridement. After 1 week of therapy, clinical and laboratory improvements were found and at the next follow-up renal function returned to baseline about 2 weeks later.

References

Couser William G. Basic and Translational Concepts of Immune-Mediated Glomerular Diseases. J Am Soc Nephrol 2012: 23; 381–399.

[DOI: https://doi.org/10.1681/ASN.2011030304]

Kurts C, Panzer U, Anders HJ, Rees AJ. The immune system and kidney disease: basic concepts and clinical implications. Nat Rev Immunol. 2013 Oct;13(10):738-53.

[doi: 10.1038/nri3523]

Yang TJ, Shah H, Olagunju A, et al. Role of steroids in post-streptococcal glomerulonephritis without crescents on renal biopsy. Cureus, 2018: 10(8); e3150. [DOI: 10.7759/cureus.3150]

Nasr SH, Radhakrishnan J, D’Agati VD. Bacterial infection-related glomerulonephritis in adult. Kidney International, 2013: 83; 792–803.

[DOI: 10.1038/ki.2012.407 ]

Ponticelli C, Locatelli F. Glucocorticoids in the treatment of glomerular diseases. American Society of Nephrology 2018; 13: 815-22. [DOI: https://doi.org/10.2215/CJN.12991117]

Lien JW, Mathew TH, Meadows R. Acute post-streptococcal glomerulonephritis in adults: a long-term study. Q J Med. 1979 Jan;48(189):99-111.

[PMID: 482595]

Kasahara T, Hayakawa H, Okubo S, Okugawa T, Kabuki N, Tomizawa S, Uchiyama M. Prognosis of acute poststreptococcal glomerulonephritis (APSGN) is excellent in children, when adequately diagnosed. Pediatr Int. 2001 Aug;43(4):364-7.

[doi: 10.1046/j.1442-200x.2001.01410.x.]

Kuhlmann U, Steurer J, Bollinger A, Pouliadis G, Briner J, Siegenthaler W. Inzidenz und klinische Bedeutung von Thrombosen und thromboembolischen Komplikationen bei Patienten mit nephrotischem Syndrom [Incidence and clinical significance of thromboses and thrombo-embolic complications in nephrotic syndrome patients]. Schweiz Med Wochenschr. 1981 Jul 7;111(27-28):1034-40. German.

[PMID: 7268357]

Geller SA, de Campos FPF. Renal papillary necrosis. Autops Case Rep. 2013;3(4):69-71. Published 2013 Dec 31.

[doi:10.4322/acr.2013.042]

Rodriguez-Iturbe B, Haas M. Post-Streptococcal glomerulonephritis. In: Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet]. Oklahoma City (OK): University of Oklahoma Health Sciences Center, 2016. [PMID: 26866231]

Tamez-Perez HE, Quintanilla-Flores DL, Rodriguez-Gutierrez R, et al. Steroid hyperglycaemia: prevalence, early detection and therapeutic recommendations: A narrative review. World J Diabetes 2015; 6(8): 1073-1081. [DOI: 10.4239/wjd.v6.i8.1073 ]

Joint British Diabetes Societies. Management of hyperglycaemia and steroid (glucocorticoid) therapy. JBDS-IP, 2014: 1-26.

[https://doi.org/10.1111/dme.13675]

Tamez-Perez HE, Quintanilla-Flores DL, Rodriguez-Gutierrez R, et al. Steroid hyperglycaemia: prevalence, early detection and therapeutic recommendations: A narrative review. World J Diabetes 2015; 6(8): 1073-1081. [DOI: 10.4239/wjd.v6.i8.1073 ]

Downloads

Published

2021-05-03

How to Cite

Novitasari, A. D., & Samsu, N. (2021). Challenges in Diagnostic and Management of Nephritic Syndrome in Diabetic Nephropathy Patient: a Case Report. Clinical and Research Journal in Internal Medicine, 2(1), 158–162. https://doi.org/10.21776/ub.crjim.2021.002.01.7